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Chronic kidney disease (CKD) impairs muscle protein
metabolism leading to muscle atrophy, and exercise can
counteract this muscle wasting. Here we evaluated how
resistance exercise (muscle overload) and endurance training
(treadmill running) affect CKD-induced abnormalities in
muscle protein metabolism and progenitor cell function
using mouse plantaris muscle. Both exercise models blunted
the increase in disease-induced muscle proteolysis and
improved phosphorylation of Akt and the forkhead
transcription factor FoxO1. Muscle overloading, but not
treadmill running, corrected protein synthesis and levels of
mediators of protein synthesis such as phosphorylated mTOR
and p70S6K in the muscles of mice with CKD. In these mice,
muscle overload, but not treadmill, running, increased
muscle progenitor cell number and activity as measured by
the amounts of MyoD, myogenin, and eMyHC mRNAs. Muscle
overload not only increased plantaris weight and reduced
muscle proteolysis but also corrected intracellular signals
regulating protein and progenitor cell function in mice with
CKD. Treadmill running corrects muscle proteolysis but not
protein synthesis or progenitor cell function. Our results
provide a basis for evaluating different types of exercise on
muscle atrophy in patients with chronic kidney disease.
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In patients with chronic kidney disease (CKD), a decline in
protein stores along with decreased muscle mass is associated
with increased morbidity and mortality.1,2 Mechanisms that
could cause loss of muscle protein include an increase in
protein degradation, a decrease in protein synthesis, and/or
impairment in muscle progenitor cell function. We have
found that CKD induces an increase in muscle protein
degradation that is mediated by the activation of caspase-3
and the ubiquitin–proteasome proteolytic system (UPS).3,4
Not only are these proteolytic pathways stimulated in rodent
models of CKD but there is also evidence that they are
activated in the muscles of dialysis patients.5,6 Besides
stimulating muscle protein degradation, CKD suppresses
protein synthesis, but the mechanisms underlying this defect
have not been systematically studied.4
Even less is known about the influence of CKD on the
activation of muscle progenitor cells (sometimes referred to
as satellite cells); these cells are necessary for repairing the loss
of muscle mass due to atrophic stimuli or muscle damage.7,8
Specialized functions of these cells include their ability to fuse
to produce myofibers that are crucial to the repair of injured
muscle or to the prevention of muscle atrophy that occurs in
catabolic conditions.7,8 The activation of muscle progenitor
cells can be identified by their increased expression of
regulatory proteins including MyoD and myogenin; MyoD
mediates myoblast activation and proliferation, whereas
myogenin mediates myoblast differentiation and the produc-
tion of structural proteins in muscle such as embryonic
myosin heavy chain (eMyHC).9
An important trigger of muscle wasting in CKD is abnor-
mal insulin/insulin-like growth factor 1 (IGF-1) signaling.10
For example, the increase in muscle protein degradation
induced by CKD or disorders associated with CKD,
such as inflammation, excess angiotensin II, diabetes, and
insulin resistance, arise because of defects in insulin/IGF-1
signaling.10–17 The impairment in insulin/IGF-1 signaling in
muscle leads to the activation of caspase-3 and the UPS,
resulting in accelerated protein degradation. Specifically, the
muscle atrophy that occurs with CKD decreases the phos-
phorylation of Akt (p-Akt), which reduces the phosphory-
lation of the forkhead transcription factors (FoxO), including
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FoxO1, allowing it to increase the expression of the ubiquitin
E3 ligase, atrogin-1/muscle atrophy F-box (MAFbx).10 The
increase in atrogin-1/MAFbx is associated with accelerated
muscle protein degradation by the UPS.10 As p-Akt also
leads to phosphorylation of mediators of protein synthesis,
a 70-kDa ribosomal protein S6 kinase (p70S6K) and the
mammalian target of rapamycin (mTOR), impaired insulin/
IGF-1 signaling could also suppress protein synthesis.10,18
Finally, there is evidence that p-Akt has a critical role in the
activation of muscle progenitor cells.19
Exercise has the potential of blunting CKD-induced
abnormalities in IGF-1 cellular signaling. In fact, Rabkin and
colleagues14,20 showed that resistance exercise (muscle over-
loading) in rats with CKD increased the expression of IGF-1 in
muscle as well as the levels of downstream mediators of the
IGF-1 signaling pathway, IRS-1/P13K/p-Akt (insulin receptor
substrate-1/phosphatidylinositol 3-kinase/Akt). It has been
shown that a single session of resistance exercise can augment
protein anabolism in the muscles of hemodialysis patients.21
Moreover, repeated exercise of patients with advanced CKD
can improve protein metabolism in muscle: Kopple et al.22
studied hemodialysis patients during B18 weeks of resistance
or endurance exercise and found an increase in IGF-1 protein
plus a decrease in myostatin mRNA in muscle. In the same
study of hemodialysis patients who participated in a program
of endurance (bicycle pedaling) exercise, there was reduction
in the 14-kDa actin fragment in muscle biopsies of these
patients. This indicates a suppression of the accelerated
proteolysis observed in the muscles of dialysis patients.3,6
These reports stimulated us to examine how exercise could
influence CKD-induced impairment of muscle metabolism.
We evaluated whether different types of exercise could
counteract CKD-induced muscle wasting by studying two
models of exercise in mice, muscle overloading and treadmill
running. We confirmed that CKD increases protein degrada-
tion and decreases protein synthesis in muscle.4 However,
CKD-induced defects in muscle protein metabolism res-
ponded to the two types of exercise differently. We found that
the differences in responses of muscle protein metabolism
were related to changes in cellular signaling pathways. We
also found evidence that progenitor cell abnormalities may
contribute to muscle atrophy in CKD.
RESULTS
The response of muscle weights to muscle overloading and
treadmill running
In CKD mice, blood urea nitrogen (BUN) values were two-
to three-fold higher than in control mice (Table 1). In normal
mice with muscle overloading or treadmill running, plantaris
muscle weights increased significantly compared with
muscle weights in unexercised normal mice. CKD-induced
muscle wasting in the two models of exercise differed; in
CKD mice with muscle overloading, plantaris weights
were 67% greater than in unexercised CKD mice (Po0.05),
whereas plantaris weights of CKD mice trained in treadmill
running did not differ from weights of pair-fed, unexercised,
CKD mice. A statistical comparison among groups of mice
with muscle overload and those with treadmill running is not
appropriate as the mice were not paired. However, it appears
that muscle overloading induced a more robust increase in
plantaris weights compared with treadmill running.
Muscle overloading and treadmill running blunt
CKD-induced muscle protein degradation
With CKD, the rate of protein degradation was 28% higher
in the plantaris muscle of unexercised mice compared with
the results in control mice (Figure 1a). Muscle overloading
lowered the CKD-induced proteolysis by 57% (Po0.01) to
a level only 12% above the value in normal, unexercised
mice. A similar pattern occurred in treadmill running mice;
the actual rates of protein breakdown are shown in
Supplementary Figure S1. Thus, both types of exercise
blunted CKD-induced acceleration of protein degradation.
To investigate why exercise suppressed CKD-induced
muscle protein degradation, we examined cell signaling path-
ways that influence muscle proteolysis.11,15,23,24 In the muscle
of CKD mice, the level of Akt serine 473 phosphorylation
(p-Akt) was depressed and both models of exercise reversed
this defect to control levels (Figure 2a and b). Similarly, the
forkhead transcription factor-1 (p-FoxO1) phosphorylation
Table 1 | Body weight and muscle weight
Body weight (g) Plantaris weight (mg) Muscle/body (100, ratio) BUN (mg %)
Resistance
Control (n¼ 6) 30.7±2.1 16.8±1.0 0.54±1.5 31.6±1.0
OL (n¼ 6) 29.1±2.5 31.8±3.6* 1.09±1.4* 30.7±0.7
CKD (n¼ 9) 22.7±1.25* 12.9±0.8* 0.56±0.6 101.8±13.9*
CKDþOL (n¼ 9) 25.1±0.8* 21.6±1.6#,y 0.86±1.2*,#,y 93.3±10.6*
Endurance
Control (n¼ 6) 29.4±3.1 17.5±2.6 0.59±0.1 30.2±0.9
Tm (n¼ 6) 27.7±2.7# 23.4±1.7* 0.84±0.2* 29.9±0.3
CKD (n¼ 9) 22.9±1.8* 11.6±1.7* 0.51±0.1 75.8±9.9*
CKDþ Tm (n¼ 9) 22.8±3.1* 13.1±1.8 0.57±0.1 69.3±9.6*
BUN, blood urea nitrogen; CKD, chronic kidney disease; OL, overload; Tm, treadmill.
All data are presented as mean±s.e.
*Po0.05 vs control; #Po0.05 vs CKD; yPo0.05 vs CKDþ Tm.
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levels at threonine 24/32 were decreased by CKD, and these
lower levels were reversed in mice by either muscle over-
loading or treadmill running. These measurements are
relevant because a decrease in p-Akt results in dephos-
phorylated FoxO1, which migrates into the nucleus to
stimulate expression of the E3 ubiquitin ligase, atrogin-1/
MAFbx, resulting in increased protein degradation.15,23,24 In
agreement with this signaling pathway, we found a significant
increase in the mRNAs of ubiquitin E3 ligases, atrogin-1/
MAFbx and MuRF1, in the muscle of CKD mice with muscle
overload or in those exercised by treadmill running compared
with values in the muscle of unexercised, CKD mice
(Supplementary Figure S3). We also evaluated the activation
of another proteolytic system in muscle, caspase-3, by
measuring the level of the 14-kDa actin fragment.3,6,10,14
Both muscle overloading and treadmill running significantly
suppressed CKD-induced actin cleavage (Figure 2c).
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Figure 1 |Both plantaris overloading and treadmill running
suppress CKD-induced muscle protein degradation. Rates of
protein degradation were measured in isolated plantaris muscles
from the following groups of mice: unexercised, control; CKD;
overloading (OL); CKD with overloading (CKDþOL); treadmill
running (TM); and CKD with treadmill running (CKD þ TM).
The results are expressed as the percentage change from values
in the muscles of unexercised, control mice (baseline). Values
are presented as the mean±s.e. (n¼ 9 per group). Differences
detected were *Po0.05 vs values in the muscle of unexercised,
control mice; and #Po0.05 vs values in unexercised mice with CKD.
CKD, chronic kidney disease.
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Figure 2 |Both plantaris overloading and treadmill running attenuate the CKD-induced decline in phosphorylation of Akt and
FoxO1 and suppression of actin cleavage. (a) The phosphorylation of Akt serine 473 and FoxO1 threonine 24/32 in plantaris muscles
was assessed by western blot analysis in the following groups of mice: control (C); CKD; overloading (OL); and CKD þ overloading
(CKDþOL) (top). The bars represent the ratio of the phosphorylated mediator to the total amount of Akt (p-Akt; left panel) and FoxO1
(p-FoxO1; right panel). Values are expressed as a percentage change from values in unexercised, control mice. The data are expressed as
a mean±s.e. of six mice in each group. Differences detected were *Po0.05 vs control muscle, and #Po0.05 vs CKD muscle. (b) Values of
p-Akt and p-FoxO1 were assessed in six mice in each group of treadmill-running (TM) mice as described for panel 2a. (c) Western blots of the
14-kDa actin fragment in plantaris muscle representing caspase-3-mediated proteolysis. The quantity of this actin fragment was calculated
as the density of the 14-kDa band divided by the density of the 42-kDa actin band. Values are the mean±s.e. and are expressed as a
percentage of the values found in the muscle of unexercised, control mice. Four mice in each group were examined and differences
detected were *Po0.05 vs value in unexercised control mice or #Po0.05 vs values in unexercised mice with CKD. Left bars: overloading;
right bars: treadmill running. CKD, chronic kidney disease.
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Muscle overloading also prevented the CKD-induced
decrease in MGF (the mechano-growth factor, muscle
isoform of IGF-1; Supplementary Figure S4). Treadmill
running also significantly increased MGF mRNA, but did
not prevent the decrease in MGF induced by CKD.
Muscle overloading counteracts the CKD-induced decrease
in protein synthesis
In normal mice, muscle overloading increased the rate of
protein synthesis to a level 18% higher than that in the
muscle of unexercised, control animals (Figure 3; Po0.01).
In unexercised CKD mice, the rate of protein synthesis was
12% lower than that in unexercised, control mice; muscle
overloading reversed the inhibition of protein synthesis. In
contrast, treadmill running did not reverse CKD-induced
suppression of muscle protein synthesis. This was unexpected
because results from normal mice indicate that treadmill
running significantly stimulated muscle protein synthesis
compared with the level found in the muscle of normal,
unexercised mice. The rates of muscle protein synthesis are
showed in Supplementary Figure S2. To determine whether
other muscles show the same responses, we measured protein
synthesis in the soleus (predominately oxidative, red fibers)
and the extensor digitorum longus (predominately glycolytic,
white fibers) muscles of mice trained in treadmill running.
There was no prevention of the effects of CKD on protein
synthesis in both muscles (data not shown).
To examine potential reasons why the responses to the
two models of exercise differed, we assessed the activation of
mediators of protein synthesis by measuring the phosphory-
lation of threonine 389 of p70S6K (p-p70S6K) and of serine
2448 of mTOR (p-mTOR) (Figure 4a and b). Muscle
overloading increased the phosphorylation of p70S6K by
five-fold (Po0.01) compared to control mice. In CKD mice,
muscle overloading reversed the lower values of p-p70S6K
(Po0.01). Changes in p-mTOR levels showed a similar
pattern: p-mTOR was significantly decreased in the muscle of
CKD mice (Po0.05) and muscle overloading reversed the
suppression of p-mTOR (Po0.01). Thus, muscle overloading
not only reversed the increase in muscle protein degradation
but also reversed the decrease in muscle protein synthesis
(reversed the suppression of mediators of protein synthesis)
caused by CKD. These beneficial responses were not found in
the muscle of mice after treadmill running: CKD was
associated with a 60% decrease in p-p70S6K compared with
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Figure 3 |Plantaris overloading counteracts the CKD-induced
suppression of muscle protein synthesis. The rates of protein
synthesis were measured in plantaris muscles from the same
groups of mice as reported in Figure 1. The results are expressed
as the percentage change from values in unexercised, control
mice (baseline). Values are presented as the mean±s.e. (n¼ 9 per
group). Differences detected were *Po0.05 vs values in the
muscle of unexercised, control mice; and #Po0.05 vs values in
unexercised mice with CKD.
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Figure 4 |Plantaris overloading counteracts CKD-induced suppression of the phosphorylation of p70S6K and mTOR in muscle.
(a) Phosphorylated mediators, p70S6K threonine 389 and mTOR serine 2448, were assessed by western blotting of plantaris muscle from the
following groups of mice: control (C); CKD; overloading (OL); and CKD overloading (CKDþOL) mice. The bars represent the ratio of the
phosphorylated p70S6K (p-p70S6K; left panel) or mTOR (p-mTOR; right panel) to GAPDH. The values are expressed as a percentage change from
values in unexercised, control mice. The data are expressed as a mean±s.e. of six mice in each group. Differences detected were *Po0.05 vs
control muscle; and #Po0.05 vs CKD muscle. (b) The same evaluations were made as in panel 4a except that the mice were subjected to
treadmill running (TM) rather than muscle overloading. CKD, chronic kidney disease; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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values in the muscle of control mice and this was not reversed
by treadmill running. Similarly, in the muscle of normal
mice, p-mTOR was increased 1.5-fold by treadmill running,
but this response was not found in the muscle of CKD mice.
Muscle overloading increases progenitor cell nuclei and
prevents CKD-induced suppression of muscle progenitor cell
markers
Muscle progenitor cells are located between the sarcolemma
and the basal lamina outside myofibers.7,8 We counted the
number of DAPI-positive nuclei outside dystrophin-stained
sarcolemma to estimate the number of muscle progenitor
cells. In the muscle of CKD mice, there was a significant
decrease (18%) in the number of nuclei outside myofibers.
However, in CKD mice with muscle overloading, the number
of these nuclei increased 1.8-fold compared with values in
the muscle of unexercised, CKD mice (Figure 5a). In CKD
mice trained in treadmill running, there was no increase in
the number of nuclei compared with unexercised CKD mice
(Figure 5b).
The expression of MyoD and myogenin was assessed as a
measure of the muscle progenitor cell activation.7,8 We
isolated muscle progenitor cells from exercised or unex-
ercised mice with or without CKD. Muscle overloading led to
increased levels of the mRNAs of MyoD (a marker of muscle
progenitor cell activation and proliferation), myogenin (a
marker of proliferation and differentiation), and eMyHC in
exercised mice (a marker of differentiation and fusion)
compared with those of muscle progenitor cells isolated from
the muscle of unexercised, normal mice. As shown in
Figure 6a, the differences included a 2.5-fold higher level of
myoD, a 1.8-fold increase in myogenin, and a 2.7-fold
increase in eMyHC expression (each, Po0.01 vs control). In
muscle progenitor cells from the muscle of CKD, the mRNAs
of MyoD, myogenin, and eMyHC were decreased by 38, 49,
and 55%, respectively, compared with the results obtained in
progenitor cells from control mice. In CKD mice with muscle
overload, these suppressed levels were reversed, surpassing
the levels present in overloaded muscles of normal mice.
In normal mice trained in treadmill running, the expres-
sion of MyoD and myogenin was significantly (Po0.05)
increased to 2- and 1.6-fold higher, respectively, compared
with values from the muscle of unexercised, normal mice
(Figure 6b). CKD depressed these values. Although treadmill
running of CKD mice raised their MyoD mRNA level, there
was no increase in the mRNA levels of myogenin and eMyHC
compared with the values in unexercised CKD mice.
DISCUSSION
In addition to nutritional approaches in overcoming muscle
atrophy in CKD patients, there is evidence that exercise could
improve muscle metabolism in CKD.6,21,22,25,26 To evaluate
the influence of exercise on CKD-induced abnormalities in
muscle protein turnover, we studied muscle overloading and
treadmill running as models of resistance and endurance
exercise. In CKD mice, we found that the two models elicited
different responses in terms of muscle growth, the compo-
nents of protein turnover and cellular signaling pathways that
can affect protein metabolism, and progenitor cells function
in muscle. Specifically, we found that both exercise models
suppressed CKD-induced muscle protein degradation. This
response was linked to the increased phosphorylation of Akt
and FoxO1 and suppressed activation of caspase-3 and the
UPS.3,15,23,25 However, the two exercise models exhibited
different responses in terms of correcting the CKD-induced
decrease in muscle protein synthesis. In mice with muscle
overloading, the decrease in muscle protein synthesis was
reversed, but with treadmill running there was only a slight
improvement in protein synthesis. Interestingly, differences
in the phosphorylation of p70S6K and mTOR reflected these
responses, linking these mediators to the improvement of
protein synthesis. In particular, muscle overloading corrected
the low levels of phosphorylated mediators of protein
synthesis, p-p70S6K and p-mTOR (Figure 4a), but treadmill
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Figure 5 |Overloading attenuates the CKD-induced decline in
progenitor cell nuclei. (a) A representative section from plantaris
muscles is shown after staining for dystrophin (red) and
counterstaining with DAPI (blue). The white arrows point to nuclei
outside of myofibers. These nuclei were used to estimate the
number of progenitor cells. The following groups of mice were
assessed: control (C); CKD; overloading (OL); and CKD overloading
(CKDþOL). The bars indicate the number of nuclei of cells
present outside myofibers in each group. Results are the
mean±s.e. (n¼ 4 per group); *Po0.05 vs values from the muscle
of unexercised, control mice; and #Po0.05 vs values from the
muscle of CKD mice. (b) The same evaluations were made as in
panel a except that the mice were subjected to treadmill running
(TM) rather than muscle overloading.
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running did not significantly improve the levels of these
mediators nor the rate of protein synthesis (Figure 4b).
The beneficial influence of muscle overloading was also
present when we evaluated CKD-induced abnormalities in
muscle progenitor cells. In the muscle of unexercised, CKD
mice, there were decreased numbers of progenitor cells
compared with findings in control mice. This abnormality
was reflected in lower levels of the mRNAs of MyoD, myo-
genin, and eMyHC, mediators of progenitor cell function.
The beneficial influence of muscle overloading on protein
synthesis in the muscle of CKD mice was reflected in
the increased expression of MyoD, myogenin, and eMyHC,
indicating increased production of muscle progenitor cells
(Figure 6a). In contrast, treadmill running of CKD mice
did not increase the number of progenitor cells nor did it
significantly improve their expression of progenitor cell
markers (Figure 6b).
These results indicate that muscle overloading can exert at
least three changes to blunt the development of muscle
atrophy, even when CKD is present: protein degradation is
suppressed, protein synthesis is stimulated, and progenitor
cells are activated. It can be noted that these functions can be
linked to increased phosphorylation of Akt.10 This conclu-
sion is supported by reports indicating that an increase in
p-Akt will suppress proteolysis by caspase-3 and the UPS, will
increase phosphorylation of p70S6K and mTOR to stimulate
protein synthesis, and will activate muscle progenitor cell
differentiation and function.15,16,23 The increase in p-Akt
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Figure 6 |Overloading attenuates the CKD-induced decline in mRNAs of myoD, myogenin, and eMyHC. (a) mRNA of myoD,
myogenin, and eMyHC in plantaris muscles of the following groups of mice: control (C); CKD; overloading (OL); and CKD overloading
(CKDþOL). The bars represent the ratio of myoD (left panel), myogenin (middle panel), or eMyHC (right panel) to 18S rRNA. The values are
expressed as a percentage change from values in unexercised, control mice. The bars represent the mean±s.e (n¼ 6 per group).
Differences detected are *Po0.05 vs values in unexercised, control mice; and #Po0.05 vs values in the muscle of CKD mice. (b) Expression of
mRNA of myoD, myogenin, and eMyHC in plantaris muscles of the following groups of mice (n¼ 6 per group): control (C); CKD; treadmill
(TM); and CKD treadmill (CKDþ TM) mice. Results (means±s.e.) are presented as described in the legend for panel a. CKD, chronic kidney
disease; eMyHC, embryonic myosin heavy chain.
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related to muscle overloading presumably relates to improved
insulin/IGF-1 signaling plus the increase in MGF expression
shown in Supplementary Figure S4.10,14
As noted in the Results section, differences in protein
turnover and progenitor cell function between muscle
overloading and treadmill running cannot be strictly
compared, as the mice were not appropriately paired. The
differences in responses of these metabolic parameters could
be influenced by a constant influence of muscle overloading
compared with the intermittent nature of treadmill running.
We attempted to examine this possibility by increasing the
intensity of treadmill running by CKD mice. However, raising
the intensity and duration of exercise increased the mortality
of CKD mice; hence, we were unable to assess how muscle
metabolism in CKD mice would respond to more prolonged
treadmill running exercise. We also did not evaluate whether
exercise-induced transitions of myofiber types contributed
to the changes we observed. It is relevant to consider the
changes in fiber types because the fiber type pattern of a
given muscle is specific for that muscle, but it can be modi-
fied by changes in muscle activity.27 Unfortunately, assigning
outcomes to changes in fiber types is difficult because
exercise also induces intermediate fibers expressing several
MyHC isoforms.27
Muscle wasting in CKD occurs when there is metabolic
acidosis, insulin resistance, excessive angiotensin II, or the
presence of inflammation.4,11,28,29 Several of these complica-
tions cause abnormalities in IRS-1/P13K/Akt signaling
resulting in decreased Akt phosphorylation.4,5,12,15,28,30 This
is relevant because exercise stimulates the local release of
growth factors, including IGF-1. We have confirmed the
report of Chen et al.14 and others31 that muscle overloading
led to an increase in p-Akt even when CKD is present. The
increase in p-Akt resulted in phosphorylation of p70S6K and
mTOR, and this in turn improved muscle protein synthesis
(Figure 3). Our finding that treadmill running did not
stimulate phosphorylation of p70S6K or mTOR was
unexpected because this exercise did increase pAkt slightly.
Perhaps the increase was insufficient to see a corresponding
increase in protein synthesis. Another possibility is that
mTOR could be phosphorylated by a p-Akt-independent
pathway.18,32 Clearly, the major effect of treadmill exercise
was through decreased protein degradation. We have no
evidence that CKD influences other hormones or growth
factors released by exercise that might affect changes in
muscle protein metabolism or progenitor cell function.20,31
An increase in muscle progenitor cell function in the
muscle overload model is especially interesting because these
cells produce new myofibers or fuse with existing myofibers
to increase muscle mass.33 The ability of muscle progenitor
cells to accomplish these tasks depends on highly regulated
expression of muscle regulatory factors. These include
MyoD, which is responsible for the exit from the cell cycle
to proliferate in order to form myotubes, and myogenin,
which promotes myoblast differentiation into myotubes.
These processes include eMyHC formation that provides a
structural protein for myotube formation.9,33 We found that
muscle overloading but not treadmill running reversed the
suppression of MyoD, myogenin, and eMyHC mRNAs
induced by CKD. How CKD and/or exercise affect signaling
mechanisms to change the expression of these factors has not
been reported, but others have provided information about
the influence of exercise on muscle progenitor cells.
Consistent with our results, Pislander et al.34 reported that
myogenin and myoD mRNA levels in human muscle were
100–400% higher after a single bout of resistance training.
Yang et al.35 found an increase in the mRNAs of MyoD (5.8-
fold) and myogenin (3.5-fold) with resistance exercise; these
factors did not change with a running exercise regimen.
In conclusion, impaired muscle growth due to CKD can
be improved in a mouse model of resistance exercise.
Mechanisms for this response include improvements in
protein synthesis, protein degradation, and muscle progeni-
tor cell function, and each is related to improved signaling
through the insulin/IGF-1 pathway. In contrast, the model
of treadmill running partially suppressed protein degradation
but did not stimulate protein synthesis or improve muscle
progenitor cell function. We recognize that the two types of
exercise cannot be rigorously compared because of differ-
ences in experimental design. We also acknowledge that
patients with CKD might respond differently to the two types
of exercise. The results, however, do provide insights into the
mechanisms that might correct CKD-induced muscle wast-
ing, and they provide experimental information that could be
useful in designing a clinical trial of exercise in CKD.
MATERIALS AND METHODS
Animals and CKD model
The experiments were approved by the Institutional Animal Care
and Use Committee of Emory University (protocol 141-2008). Mice
(C57BL/6J) were kept in a 12-h light/12-h dark cycle. CKD was
induced by subtotal nephrectomy in anesthetized mice (12 mg/kg
xylazine and 60 mg/kg ketamine) as described.30 A right kidney was
removed through a right flank incision. The two poles of the left
kidney were excised and hemostasis was achieved by cautery and
pressure. Initially, mice were fed 14% Protein Rodent Diet Chow
(Harlan Teklad, Madison, WI, USA) ad libitum; after 7 days, control,
sham-surgery, and weight-matched mice were pair-fed (40% protein
chow) for at least 2 weeks.30 BUN was measured using the Reflotron
diagnostic device (Roche, Indianapolis, IN, USA).
Exercise training
Treadmill running. Running on a Model 1055MSD Exer-6M
treadmill (Columbus Instruments, Columbus, OH, USA) was
studied as a model of endurance exercise. Before subtotal
nephrectomy, mice ran at 15 m/min. Exercise intensity was
progressively increased over the next week until they ran at 30 m/
min. In week 2, a subtotal nephrectomy was carried out, and after
1 week of recovery, mice were exercised by running at 30 m/min for
30 min each day for 2 weeks. Age- and weight-matched control and
pair-fed mice were exercised at the same time rate and intensity.
Plantaris muscle overloading. To evaluate a model of
resistance exercise, we studied muscle overloading. At 1 week after
subtotal nephrectomy, plantaris muscles of mice were overloaded by
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removing gastrocnemius and soleus muscles from both hindlimbs.
Control mice were sham-operated and pair-fed to muscle over-
loaded CKD mice. After 2 weeks, plantaris muscles were harvested
for study.
Skeletal muscle protein metabolism
Protein degradation in plantaris muscles was assessed as tyrosine
released into the media, whereas protein synthesis was measured
as phenylalanine incorporation into muscle as described.4,30
These amino acids were used because muscle neither synthesizes
nor degrades them and tyrosine does not accumulate in the
intracellular pool of muscle; hence, its release into the media is an
estimate of protein degradation. Phenylalanine rapidly equilibrates
with the intracellular amino acid pool in muscle and can be used to
measure protein synthesis. Details are given in Supplementary
materials.
Western blot and antibodies
Plantaris muscles were homogenized in RIPA buffer, and signaling
proteins in the soluble fraction of tissue homogenates were assessed
by western blotting.36 When we assessed the 14-kDa actin fragment,
muscles were homogenized in hypotonic buffer.3 Details of the
western blot procedure are given in the Supplementary materials.
Muscle progenitor cell isolation
To isolate muscle progenitor cells from plantaris muscles, muscles
were minced to create a coarse slurry followed by gentle agitation in
DMEM (Dulbecco’s modified Eagle’s medium) containing 25 mM
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH
7.4) plus 0.1% pronase (Calbiochem, San Diego, CA, USA) for 1 h
at 37 1C. The digest was passed through a 100-mm filter before
centrifugation through an isotonic Percoll gradient.8 The cells were
collected from the interface of the Percoll gradient.
Muscle progenitor cell number estimates
Nuclei numbers outside muscle fibers were counted in three
transverse cross-sections from frozen sections of plantaris muscles
after staining using the MOM Immunodetection Kit (Vector
Laboratories, Burlingame, CA, USA). The sections were incubated
with anti-dystrophin antibody for 30 min, followed by Fluorescein
Avidin DCS for 5 min and 40,6-diamidino-2-phenylindole dihy-
drochloride (DAPI, 500 ng/ml) for 10 min. The myofiber sarcolem-
ma was defined by dystrophin staining (red). The nuclei outside the
sarcolemma were stained with DAPI (blue) and visualized using an
Olympus 1 51 inverted fluorescence microscope; the images
were captured by a SIS-CC12 CLR camera. At least 300 individual
myofibers per muscle were measured using MicroSuite Five
Biological Software (Olympus, Melville, NY, USA).
Reverse transcription-PCR and qPCR
mRNAs for MyoD, myogenin, and eMyHC were measured by
RT-PCR, and atrogin-1/MAFbx, MuRF1and MGF mRNA were
measured by quantitative PCR (qPCR) as described.36 The detail
protocol and primer sequence are provided in Supplementary
materials.
Statistical analysis
Results are presented as mean±s.e. Data were analyzed using t-test
when comparing results from two experimental groups; ANOVA for
results from more groups. After ANOVA, pair-wise comparisons
were made using the Student–Newman–Keuls test.
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